HealthPlix introduces ‘Drug to Drug Interaction’ feature to its EMR

HealthPlix introduces ‘Drug to Drug Interaction’ feature to its EMR

• HealthPlix Technologies announced the release of its new feature - ‘ Drug to Drug Interaction ’ (DDI).
• The feature is live on the company’s platform and optimised for prompting these interactions while the doctor prescribes the medicines to their patients.
• Commenting on the feature release, Subhadeep Mondal, Vice President - Products, HealthPlix Technologies said, “By suggesting interactions between incompatible drugs, this new DDI feature will assist them.
• With a robust global interaction library in place, we intend to partner with organisations who specialise in drug-drug interactions, as well as citing research publications to back up our claims.
• The best part is that it displays on the screen but does not print out on paper.
• HealthPlix expects its reference interaction library to grow from 4L-10L by March 2023.

For more such updates, trends and insights on healthcare technology visit - https://telehealthtelemedicines.com/